Alcocer-Varela, J., Alarcon-Segovia, D., 1982. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest 69, 1388-1392.

Aubol, B.E., Serrano, P., Fattet, L., Wuthrich, K., Adams, J.A., 2018. Molecular interactions connecting the function of the serine-arginine-rich protein SRSF1 to protein phosphatase 1. J Biol Chem 293, 16751-16760.

Bengtsson, A.A., Sturfelt, G., Truedsson, L., Blomberg, J., Alm, G., Vallin, H., Ronnblom, L., 2000. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 9, 664-671.

Chang, J.J., Woods, M., Lindsay, R.J., Doyle, E.H., Griesbeck, M., Chan, E.S., Robbins, G.K., Bosch, R.J., Altfeld, M., 2013. Higher expression of several interferon-stimulated genes in HIV-1-infected females after adjusting for the level of viral replication. J Infect Dis 208, 830-838.

Clements, J.L., Koretzky, G.A., 1999. Recent developments in lymphocyte activation: linking kinases to downstream signaling events. J Clin Invest 103, 925-929.

Crow, M.K., 2014. Type I interferon in the pathogenesis of lupus. J Immunol 192, 5459-5468.

Dall’Era, M., 2013. Chapter 21. Systemic Lupus Erythematosus, in: Imboden, J.B., Hellmann, D.B., Stone, J.H. (Eds.), CURRENT Diagnosis & Treatment: Rheumatology, 3e. The McGraw-Hill Companies, New York, NY.

Das, S., Fregoso, O.I., Krainer, A.R., 2013. A new path to oncogene-induced senescence: at the crossroads of splicing and translation. Cell Cycle 12, 1477-1479.

Gronski, M.A., Kinchen, J.M., Juncadella, I.J., Franc, N.C., Ravichandran, K.S., 2009. An essential role for calcium flux in phagocytes for apoptotic cell engulfment and the anti-inflammatory response. Cell Death Differ 16, 1323-1331.

Kammer, G.M., Perl, A., Richardson, B.C., Tsokos, G.C., 2002. Abnormal T cell signal transduction in systemic lupus erythematosus. Arthritis Rheum 46, 1139-1154.

Katsuyama, T., Li, H., Comte, D., Tsokos, G.C., Moulton, V.R., 2019. Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity. J Clin Invest 129, 5411-5423.

Katsuyama, T., Li, H., Krishfield, S.M., Kyttaris, V.C., Moulton, V.R., 2021. Splicing factor SRSF1 limits IFN-gamma production via RhoH and ameliorates experimental nephritis. Rheumatology (Oxford) 60, 420-429.

Katsuyama, T., Martin-Delgado, I.J., Krishfield, S.M., Kyttaris, V.C., Moulton, V.R., 2020. Splicing factor SRSF1 controls T cell homeostasis and its decreased levels are linked to lymphopenia in systemic lupus erythematosus. Rheumatology (Oxford) 59, 2146-2155.

Katsuyama, T., Moulton, V.R., 2021. Splicing factor SRSF1 is indispensable for regulatory T cell homeostasis and function. Cell Rep 36, 109339.

Katsuyama, T., Tsokos, G.C., Moulton, V.R., 2018. Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus. Front Immunol 9, 1088.

Kaul, A., Gordon, C., Crow, M.K., Touma, Z., Urowitz, M.B., van Vollenhoven, R., Ruiz-Irastorza, G., Hughes, G., 2016. Systemic lupus erythematosus. Nat Rev Dis Primers 2, 16039.

Kozyrev, S.V., Bernal-Quiros, M., Alarcon-Riquelme, M.E., Castillejo-Lopez, C., 2012. The dual effect of the lupus-associated polymorphism rs10516487 on BANK1 gene expression and protein localization. Genes Immun 13, 129-138.

Kyogoku, C., Smiljanovic, B., Grun, J.R., Biesen, R., Schulte-Wrede, U., Haupl, T., Hiepe, F., Alexander, T., Radbruch, A., Grutzkau, A., 2013. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference? PLoS One 8, e83776.

Laurence, A., Tato, C.M., Davidson, T.S., Kanno, Y., Chen, Z., Yao, Z., Blank, R.B., Meylan, F., Siegel, R., Hennighausen, L., Shevach, E.M., O’Shea J, J., 2007. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26, 371-381.

Liao, X., Pirapakaran, T., Luo, X.M., 2016. Chemokines and Chemokine Receptors in the Development of Lupus Nephritis. Mediators Inflamm 2016, 6012715.

Linker-Israeli, M., Bakke, A.C., Kitridou, R.C., Gendler, S., Gillis, S., Horwitz, D.A., 1983. Defective production of interleukin 1 and interleukin 2 in patients with systemic lupus erythematosus (SLE). J Immunol 130, 2651-2655.

Liu, W., Li, M., Wang, Z., Wang, J., 2020. IFN-gamma Mediates the Development of Systemic Lupus Erythematosus. Biomed Res Int 2020, 7176515.

Lourenco, E.V., La Cava, A., 2009. Cytokines in systemic lupus erythematosus. Curr Mol Med 9, 242-254.

Maslon, M.M., Heras, S.R., Bellora, N., Eyras, E., Caceres, J.F., 2014. The translational landscape of the splicing factor SRSF1 and its role in mitosis. Elife, e02028.

Moulton, V.R., Gillooly, A.R., Perl, M.A., Markopoulou, A., Tsokos, G.C., 2015. Serine Arginine-Rich Splicing Factor 1 (SRSF1) Contributes to the Transcriptional Activation of CD3zeta in Human T Cells. PLoS One 10, e0131073.

Moulton, V.R., Gillooly, A.R., Tsokos, G.C., 2014. Ubiquitination regulates expression of the serine/arginine-rich splicing factor 1 (SRSF1) in normal and systemic lupus erythematosus (SLE) T cells. J Biol Chem 289, 4126-4134.

Moulton, V.R., Grammatikos, A.P., Fitzgerald, L.M., Tsokos, G.C., 2013. Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription. Proc Natl Acad Sci U S A 110, 1845-1850.

Moulton, V.R., Kyttaris, V.C., Juang, Y.T., Chowdhury, B., Tsokos, G.C., 2008. The RNA-stabilizing protein HuR regulates the expression of zeta chain of the human T cell receptor-associated CD3 complex. J Biol Chem 283, 20037-20044.

Moulton, V.R., Tsokos, G.C., 2010. Alternative splicing factor/splicing factor 2 regulates the expression of the zeta subunit of the human T cell receptor-associated CD3 complex. J Biol Chem 285, 12490-12496.

Moulton, V.R., Tsokos, G.C., 2015. T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity. J Clin Invest 125, 2220-2227.

Reyes, M., Vickers, D., Billman, K., Eisenhaure, T., Hoover, P., Browne, E.P., Rao, D.A., Hacohen, N., Blainey, P.C., 2019. Multiplexed enrichment and genomic profiling of peripheral blood cells reveal subset-specific immune signatures. Sci Adv 5, eaau9223.

Sadler, A.J., Williams, B.R., 2008. Interferon-inducible antiviral effectors. Nat Rev Immunol 8, 559-568.

Schmeisser, H., Mejido, J., Balinsky, C.A., Morrow, A.N., Clark, C.R., Zhao, T., Zoon, K.C., 2010. Identification of alpha interferon-induced genes associated with antiviral activity in Daudi cells and characterization of IFIT3 as a novel antiviral gene. J Virol 84, 10671-10680.

Sharabi, A., Kasper, I.R., Tsokos, G.C., 2018. The serine/threonine protein phosphatase 2A controls autoimmunity. Clin Immunol 186, 38-42.

Thompson, M.R., Sharma, S., Atianand, M., Jensen, S.B., Carpenter, S., Knipe, D.M., Fitzgerald, K.A., Kurt-Jones, E.A., 2014. Interferon gamma-inducible protein (IFI) 16 transcriptionally regulates type i interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses. J Biol Chem 289, 23568-23581.

van Der Houven Van Oordt, W., Newton, K., Screaton, G.R., Caceres, J.F., 2000. Role of SR protein modular domains in alternative splicing specificity in vivo. Nucleic Acids Res 28, 4822-4831.

Wu, C., Zhao, Y., Lin, Y., Yang, X., Yan, M., Min, Y., Pan, Z., Xia, S., Shao, Q., 2018. Bioinformatics analysis of differentially expressed gene profiles associated with systemic lupus erythematosus. Mol Med Rep 17, 3591-3598.

Ytterberg, S.R., Schnitzer, T.J., 1982. Serum interferon levels in patients with systemic lupus erythematosus. Arthritis Rheum 25, 401-406.